Secondary Monoclonal Gammopathy of Undetermined Significance After Allogeneic Stem Cell Transplantation in Multiple Myeloma

Blood- United States

doi 10.1182/blood.v124.21.1238.1238

Full Text

Abstract

Available in

Categories

Date

December 6, 2014

Authors

Laurens Franssen

Suzanne van Dorp

Henk M. Lokhorst

Niels W.C.J. van de Donk

Publisher

American Society of Hematology

Related search

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports

Cancer Research

English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America

English

FOXP1 Expression in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Pathology International

Forensic Medicine

English

Monoclonal Gammopathy of Undetermined Significance

English

Single-Nucleotide Polymorphism Rs1052501 Associated With Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Cancer Research

English

Circulating miRNAs as Diagnostic Biomarkers for Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Journal of Clinical Laboratory Analysis

Medical Laboratory Technology

Clinical Biochemistry

Occupational Health

English

Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma

Seminars in Hematology

English

Prior Autoimmune Disease and Risk of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Systematic Review

Cancer Epidemiology Biomarkers and Prevention

English

Autologous Peripheral Blood Stem Cell Transplantation for Peripheral Neuropathy Secondary to Monoclonal Gammopathy of Unknown Significance

Bone Marrow Transplantation

Transplantation

English